What is XyloCor Therapeutics worth?
$130.0Mlast known valuation
XyloCor Therapeutics last raised $4.0M in its Seed Round (Jan 2021).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for XyloCor Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2021 | Seed Round | $4.0M | ▮ | ▮ |
| Oct 2018 | Early Stage VC | $16.8M | ▮ | ▮ |
| Nov 2016 | Debt | $250K | ▮ | ▮ |
How XyloCor Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For XyloCor Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is XyloCor Therapeutics worth?
- XyloCor Therapeutics's last known valuation is $130.0M.
- How much has XyloCor Therapeutics raised?
- XyloCor Therapeutics has raised $122.0M in total funding across 3 recorded rounds.
- When did XyloCor Therapeutics last raise?
- XyloCor Therapeutics last raised in Jan 2021 (Seed Round), raising $4.0M.